Home/Filings/8-K/0001104659-26-002901
8-K//Current report

MAXCYTE, INC. 8-K

Accession 0001104659-26-002901

$MXCTCIK 0001287098operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 4:45 PM ET

Size

187.9 KB

Accession

0001104659-26-002901

Research Summary

AI-generated summary of this filing

Updated

MaxCyte, Inc. Announces Preliminary Q4 and FY2025 Results

What Happened
MaxCyte, Inc. announced on January 12, 2026 that it released preliminary unaudited financial results for the quarter and fiscal year ended December 31, 2025. The company furnished a press release reporting these preliminary results, which is attached to the Form 8‑K as Exhibit 99.1. The filing was signed by Chief Financial Officer Douglas Swirsky.

Key Details

  • Date filed: January 12, 2026.
  • Reporting period: quarter and fiscal year ended December 31, 2025.
  • Nature of results: preliminary and unaudited (released via press release attached as Exhibit 99.1).
  • Form 8‑K was furnished (not filed) to disclose the press release.

Why It Matters
Preliminary unaudited results give investors an early view of the company’s recent financial performance ahead of the final audited statements and formal earnings filings. Because these figures are preliminary and unaudited, they may be updated when MaxCyte files its final quarterly/fiscal reports or releases audited numbers, so investors should review the attached press release and await the company’s subsequent filings for complete, audited details.